Loss of CD24 promotes radiation‑ and chemo‑resistance by inducing stemness properties associated with a hybrid E/M state in breast cancer cells.

CD24 Antigen / genetics Reactive Oxygen Species / metabolism Hyaluronan Receptors / genetics Neoplastic Stem Cells / metabolism Epithelial-Mesenchymal Transition Cell Differentiation Cell Line, Tumor Neoplasms / pathology
CD24 breast cancer cancer stem cells epithelial-mesenchymal transition resistance

Journal

Oncology reports
ISSN: 1791-2431
Titre abrégé: Oncol Rep
Pays: Greece
ID NLM: 9422756

Informations de publication

Date de publication:
Jan 2023
Historique:
received: 04 07 2022
accepted: 10 10 2022
entrez: 11 11 2022
pubmed: 12 11 2022
medline: 15 11 2022
Statut: ppublish

Résumé

Cancer stem cells (CSCs) serve an essential role in failure of conventional antitumor therapy. In breast cancer, CD24

Identifiants

DOI: 10.3892/or.2022.8441 PMID: 36367190 PMC: PMC9685273
pubmed: 36367190
doi: 10.3892/or.2022.8441
pii: 4
pmc: PMC9685273
doi:
pii:

Substances chimiques

CD24 Antigen 0
Reactive Oxygen Species 0
Hyaluronan Receptors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Genes Dev. 2001 Jan 1;15(1):50-65
pubmed: 11156605
Oncol Rep. 2017 Sep;38(3):1867-1876
pubmed: 28731185
Oncotarget. 2018 May 4;9(34):23519-23531
pubmed: 29805752
Cancer Res. 2020 Sep 15;80(18):3933-3944
pubmed: 32661136
Clin Exp Immunol. 1993 Aug;93(2):279-85
pubmed: 7688677
PLoS One. 2013 Oct 04;8(10):e76773
pubmed: 24124593
PLoS One. 2008 Aug 06;3(8):e2888
pubmed: 18682804
Int J Radiat Biol. 1994 Jan;65(1):27-33
pubmed: 7905906
Proc Natl Acad Sci U S A. 2016 Oct 11;113(41):E6107-E6116
pubmed: 27681615
J Clin Pathol. 2011 Nov;64(11):937-46
pubmed: 21680574
Breast Cancer Res. 2016 May 24;18(1):55
pubmed: 27220421
PLoS Comput Biol. 2015 Nov 10;11(11):e1004569
pubmed: 26554584
Biomolecules. 2019 Nov 27;9(12):
pubmed: 31783552
PLoS One. 2013;8(2):e56679
pubmed: 23441212
Stem Cell Reports. 2014 Nov 11;3(5):691-8
pubmed: 25316190
Cell. 2008 May 16;133(4):704-15
pubmed: 18485877
Semin Cancer Biol. 2019 Oct;58:109-117
pubmed: 30149066
Cancer Lett. 2013 Nov 28;341(1):56-62
pubmed: 23830804
Semin Cancer Biol. 2022 Jul;82:11-25
pubmed: 33737107
Cell Death Dis. 2018 Aug 30;9(9):896
pubmed: 30166520
Trends Cell Biol. 2019 Mar;29(3):212-226
pubmed: 30594349
J Natl Cancer Inst. 2006 Dec 20;98(24):1777-85
pubmed: 17179479
Mol Med Rep. 2019 Sep;20(3):2339-2346
pubmed: 31322179
J Natl Cancer Inst. 2008 May 7;100(9):672-9
pubmed: 18445819
Drug Resist Updat. 2021 Jan;54:100742
pubmed: 33429249
Br J Cancer. 2021 Jun;124(12):1902-1911
pubmed: 33859341
Mol Carcinog. 2016 Mar;55(3):245-54
pubmed: 25641732
BMC Bioinformatics. 2006 Nov 30;7:520
pubmed: 17137497
Proc Natl Acad Sci U S A. 2019 Apr 9;116(15):7353-7362
pubmed: 30910979
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8
pubmed: 12629218
Oncotarget. 2016 Jan 5;7(1):771-85
pubmed: 26506421
Oncogene. 2013 Jan 10;32(2):251-8
pubmed: 22330142
Nat Protoc. 2014 Aug;9(8):1931-43
pubmed: 25033209
Cells. 2021 Jan 06;10(1):
pubmed: 33419140
Oncogene. 2016 Jul 21;35(29):3781-95
pubmed: 26640144
Nat Med. 2017 Oct 6;23(10):1124-1134
pubmed: 28985214
NPJ Breast Cancer. 2017 Jun 6;3:21
pubmed: 28649661
J Exp Pharmacol. 2021 Mar 18;13:303-328
pubmed: 33776489
Stem Cell Reports. 2013 Dec 27;2(1):78-91
pubmed: 24511467
Oncol Rep. 2009 Nov;22(5):1149-56
pubmed: 19787233
Cell Mol Immunol. 2010 Mar;7(2):100-3
pubmed: 20154703
Mol Cancer Res. 2005 Sep;3(9):519-29
pubmed: 16179499
FEBS J. 2017 Oct;284(19):3132-3144
pubmed: 28444969
Molecules. 2018 Aug 30;23(9):
pubmed: 30200262
Mol Cell. 2014 Oct 2;56(1):140-52
pubmed: 25240402
Methods Enzymol. 2012;504:183-200
pubmed: 22264535
Oncotarget. 2017 Jun 13;8(24):39401-39416
pubmed: 28455959
Oncotarget. 2018 Apr 13;9(28):20018-20033
pubmed: 29732000
iScience. 2022 Apr 27;25(5):104317
pubmed: 35602941
Cell Stem Cell. 2007 Nov;1(5):555-67
pubmed: 18371393
Cancer Converg. 2020;4(1):1
pubmed: 32090168
Semin Radiat Oncol. 2002 Oct;12(4):296-304
pubmed: 12382188
Oncotarget. 2017 Jun 13;8(24):38294-38308
pubmed: 28418843
PLoS One. 2013 Apr 30;8(4):e62493
pubmed: 23638097
Curr Pharm Des. 2015;21(10):1301-10
pubmed: 25506895
J Clin Med. 2019 Jun 21;8(6):
pubmed: 31234417
Cell. 2010 Jan 8;140(1):62-73
pubmed: 20074520
Breast Cancer Res. 2009;11(6):R82
pubmed: 19906290
Cell Stem Cell. 2019 Jan 3;24(1):65-78
pubmed: 30554963
Sci Rep. 2017 Oct 23;7(1):13856
pubmed: 29062075
Clin Cancer Res. 2009 Jun 15;15(12):4234-41
pubmed: 19509181
Cancer Genomics Proteomics. 2021 May-Jun;18(3 Suppl):471-486
pubmed: 33994369
Cells. 2020 Jul 15;9(7):
pubmed: 32679735
Nature. 2018 Apr;556(7702):463-468
pubmed: 29670281
Nat Rev Cancer. 2003 May;3(5):330-8
pubmed: 12724731
J Vis Exp. 2015 Mar 22;(97):
pubmed: 25867607
Nature. 2009 Apr 9;458(7239):780-3
pubmed: 19194462
PLoS One. 2009 Dec 21;4(12):e8377
pubmed: 20027313
Int J Cancer. 2021 Feb 1;148(3):546-559
pubmed: 32790899
J Clin Med. 2020 Dec 26;10(1):
pubmed: 33375334
Cell. 2011 Aug 19;146(4):633-44
pubmed: 21854987
Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):E2337-E2346
pubmed: 28270621
Oxid Med Cell Longev. 2016;2016:2428153
pubmed: 26682001
Lab Invest. 2010 Jul;90(7):1102-16
pubmed: 20351695
Integr Biol (Camb). 2019 Jun 1;11(6):251-263
pubmed: 31329868
Carcinogenesis. 2009 Mar;30(3):432-9
pubmed: 19126655
Nat Rev Cancer. 2012 Apr 19;12(5):323-34
pubmed: 22513401

Auteurs

Isaline Bontemps (I)

Laboratory of Experimental Cancerology, Institute of Cellular and Molecular Radiobiology, Genetic Stability Stem Cells and Radiation, François Jacob Institute of Biology, French Alternative Energies and Atomic Energy Commission (CEA), Paris University and Paris‑Saclay University, F‑92265 Fontenay‑aux‑Roses, France.

Celine Lallemand (C)

Laboratory of Experimental Cancerology, Institute of Cellular and Molecular Radiobiology, Genetic Stability Stem Cells and Radiation, François Jacob Institute of Biology, French Alternative Energies and Atomic Energy Commission (CEA), Paris University and Paris‑Saclay University, F‑92265 Fontenay‑aux‑Roses, France.

Denis Biard (D)

Unit of Prion Disorders and Related Infectious Agents, François Jacob Institute of Biology, CEA, Paris‑Saclay University, F‑92265 Fontenay‑aux‑Roses, France.

Nathalie Dechamps (N)

Laboratory of Radiopathology, Institute of Cellular and Molecular Radiobiology, Genetic Stability Stem Cells and Radiation, François Jacob Institute of Biology, CEA, French National Health and Medical Research Institute U1274, Paris University and Paris‑Saclay University, F‑92265 Fontenay‑aux‑Roses, France.

Thierry Kortulewski (T)

Laboratory of Radiopathology, Institute of Cellular and Molecular Radiobiology, Genetic Stability Stem Cells and Radiation, François Jacob Institute of Biology, CEA, French National Health and Medical Research Institute U1274, Paris University and Paris‑Saclay University, F‑92265 Fontenay‑aux‑Roses, France.

Emmanuelle Bourneuf (E)

Laboratory of Experimental Cancerology, Institute of Cellular and Molecular Radiobiology, Genetic Stability Stem Cells and Radiation, François Jacob Institute of Biology, French Alternative Energies and Atomic Energy Commission (CEA), Paris University and Paris‑Saclay University, F‑92265 Fontenay‑aux‑Roses, France.

Capucine Siberchicot (C)

Laboratory of Experimental Cancerology, Institute of Cellular and Molecular Radiobiology, Genetic Stability Stem Cells and Radiation, François Jacob Institute of Biology, French Alternative Energies and Atomic Energy Commission (CEA), Paris University and Paris‑Saclay University, F‑92265 Fontenay‑aux‑Roses, France.

François Boussin (F)

Laboratory of Radiopathology, Institute of Cellular and Molecular Radiobiology, Genetic Stability Stem Cells and Radiation, François Jacob Institute of Biology, CEA, French National Health and Medical Research Institute U1274, Paris University and Paris‑Saclay University, F‑92265 Fontenay‑aux‑Roses, France.

Sylvie Chevillard (S)

Laboratory of Experimental Cancerology, Institute of Cellular and Molecular Radiobiology, Genetic Stability Stem Cells and Radiation, François Jacob Institute of Biology, French Alternative Energies and Atomic Energy Commission (CEA), Paris University and Paris‑Saclay University, F‑92265 Fontenay‑aux‑Roses, France.

Anna Campalans (A)

Laboratory of Experimental Cancerology, Institute of Cellular and Molecular Radiobiology, Genetic Stability Stem Cells and Radiation, François Jacob Institute of Biology, French Alternative Energies and Atomic Energy Commission (CEA), Paris University and Paris‑Saclay University, F‑92265 Fontenay‑aux‑Roses, France.

Jerome Lebeau (J)

Laboratory of Experimental Cancerology, Institute of Cellular and Molecular Radiobiology, Genetic Stability Stem Cells and Radiation, François Jacob Institute of Biology, French Alternative Energies and Atomic Energy Commission (CEA), Paris University and Paris‑Saclay University, F‑92265 Fontenay‑aux‑Roses, France.

Articles similaires

Spatial multiplex analysis of lung cancer reveals that regulatory T cells attenuate KRAS-G12C inhibitor-induced immune responses.

Megan Cole, Panayiotis Anastasiou, Claudia Lee et al.
1.00
T-Lymphocytes, Regulatory Lung Neoplasms Proto-Oncogene Proteins p21(ras) Animals Humans

Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis.

Spencer D Shelton, Sara House, Luiza Martins Nascentes Melo et al.
1.00
DNA, Mitochondrial Humans Melanoma Mutation Neoplasm Metastasis

Patients' knowledge about renal secondary effects of anti-tumoral drugs and renal protection measures.

Pauline Corbaux, Matthieu Bainaud, Adrien Rousseau et al.
1.00
Humans Male Female Health Knowledge, Attitudes, Practice Middle Aged

Decorin-armed oncolytic adenovirus promotes natural killers (NKs) activation and infiltration to enhance NK therapy in CRC model.

Xue Li, Yuning Zhang, Zhuang Mao et al.
1.00
Killer Cells, Natural Animals Colorectal Neoplasms Decorin Adenoviridae

Classifications MeSH

questionsmedicales.fr › Facteurs biologiques › Antigènes › Antigènes de surface › Molécules d'adhérence cellulaire › Antigènes CD24 › Loss of CD24 promotes radiation‑ and...
questionsmedicales.fr › Produits chimiques inorganiques › Composés de l'oxygène › Espèces réactives de l'oxygène › Loss of CD24 promotes radiation‑ and...
questionsmedicales.fr › Facteurs biologiques › Antigènes › Antigènes de surface › Molécules d'adhérence cellulaire › Récepteurs d'écotaxie des lymphocytes › Antigènes CD44 › Loss of CD24 promotes radiation‑ and...
questionsmedicales.fr › Cellules › Cellules souches › Cellules souches tumorales › Loss of CD24 promotes radiation‑ and...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Transdifférenciation cellulaire › Transition épithélio-mésenchymateuse › Loss of CD24 promotes radiation‑ and...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Différenciation cellulaire › Loss of CD24 promotes radiation‑ and...
questionsmedicales.fr › Cellules › Cellules cultivées › Cellules cancéreuses en culture › Lignée cellulaire tumorale › Loss of CD24 promotes radiation‑ and...
questionsmedicales.fr › Tumeurs › Loss of CD24 promotes radiation‑ and...